Home >
The Specialty Drug Price Debate: Should Medtech be worried?
News
<>
June 30, 2015
The MedTech Strategist
The Specialty Drug Price Debate: Should Medtech be worried?
By
David Cassak
As prices for specialty drugs like oncologics soar, outrage is mounting over the cost of the new therapies, prompting a debate about their value.Could any of this spill over to medical devices?